2055 related articles for article (PubMed ID: 15252738)
21. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
[TBL] [Abstract][Full Text] [Related]
22. Total serum homocysteine, folate and vitamin B12 in a Greek school age population.
Papandreou D; Mavromichalis I; Makedou A; Rousso I; Arvanitidou M
Clin Nutr; 2006 Oct; 25(5):797-802. PubMed ID: 16690175
[TBL] [Abstract][Full Text] [Related]
23. [Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?].
Méndez-González J; Rodríguez-Millán E; Julve J; Blanco-Vaca F
Rev Neurol; 2010 Feb 16-28; 50(4):235-44. PubMed ID: 20198596
[TBL] [Abstract][Full Text] [Related]
24. [Homocysteine and cardiovascular risk].
Auer J; Berent R; Weber T; Lassnig E; Eber B
Wien Med Wochenschr; 2001; 151(1-2):25-8. PubMed ID: 11234594
[TBL] [Abstract][Full Text] [Related]
25. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
26. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
Vianna AC; Mocelin AJ; Matsuo T; Morais-Filho D; Largura A; Delfino VA; Soares AE; Matni AM
Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173
[TBL] [Abstract][Full Text] [Related]
27. [Consequences of moderate hyperhomocysteinemia in internal medicine].
Zák A; Zeman M
Cas Lek Cesk; 2004; 143(6):367-74. PubMed ID: 15309862
[TBL] [Abstract][Full Text] [Related]
28. Homocysteine--relevant for atherogenesis?
Kircher T; Sinzinger H
Wien Klin Wochenschr; 2000 Jun; 112(12):523-32. PubMed ID: 10953870
[TBL] [Abstract][Full Text] [Related]
29. Metabolism of homocysteine and its relationship with cardiovascular disease.
Aguilar B; Rojas JC; Collados MT
J Thromb Thrombolysis; 2004 Oct; 18(2):75-87. PubMed ID: 15789174
[TBL] [Abstract][Full Text] [Related]
30. Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations.
Green TJ; Skeaff CM; McMahon JA; Venn BJ; Williams SM; Devlin AM; Innis SM
Br J Nutr; 2010 Jun; 103(11):1629-34. PubMed ID: 20089204
[TBL] [Abstract][Full Text] [Related]
31. Role of vitamins B6, B12 and folic acid on hyperhomocysteinemia in a Pakistani population of patients with acute myocardial infarction.
Iqbal MP; Ishaq M; Kazmi KA; Yousuf FA; Mehboobali N; Ali SA; Khan AH; Waqar MA
Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):100-8. PubMed ID: 15871858
[TBL] [Abstract][Full Text] [Related]
32. Homocysteine: an emerging age-related cardiovascular risk factor.
Moustapha A; Robinson K
Geriatrics; 1999 Apr; 54(4):41, 44-6, 49-51. PubMed ID: 10212627
[TBL] [Abstract][Full Text] [Related]
33. Drug-induced pertubation of the aminothiol redox-status in patients with epilepsy: improvement by B-vitamins.
Apeland T; Frøyland ES; Kristensen O; Strandjord RE; Mansoor MA
Epilepsy Res; 2008 Nov; 82(1):1-6. PubMed ID: 18644700
[TBL] [Abstract][Full Text] [Related]
34. Hyperhomocysteinemia, atherosclerosis and thrombosis.
Cattaneo M
Thromb Haemost; 1999 Feb; 81(2):165-76. PubMed ID: 10063987
[TBL] [Abstract][Full Text] [Related]
35. Folate and cobalamin synergistically decrease the risk of high plasma homocysteine in a nonsupplemented elderly institutionalized population.
Huerta JM; González S; Vigil E; Prada M; San Martín J; Fernández S; Patterson AM; Lasheras C
Clin Biochem; 2004 Oct; 37(10):904-10. PubMed ID: 15369722
[TBL] [Abstract][Full Text] [Related]
36. Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years.
Wolters M; Hermann S; Hahn A
Eur J Nutr; 2005 Mar; 44(3):183-92. PubMed ID: 15309436
[TBL] [Abstract][Full Text] [Related]
37. Homocysteine and risk for atherothrombotic events.
Puddu P
Cardiologia; 1999 Jul; 44(7):627-31. PubMed ID: 10476587
[TBL] [Abstract][Full Text] [Related]
38. Significance of hyperhomocysteinemia.
Herrmann W
Clin Lab; 2006; 52(7-8):367-74. PubMed ID: 16955635
[TBL] [Abstract][Full Text] [Related]
39. The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins.
Siragusa S; Malato A; Cigna V; Anastasio R; Coco LL; Casuccio A; Ciaccio M
Thromb Res; 2007; 121(1):51-3. PubMed ID: 17462714
[No Abstract] [Full Text] [Related]
40. Folate, homocysteine, endothelial function and cardiovascular disease.
Moat SJ; Lang D; McDowell IF; Clarke ZL; Madhavan AK; Lewis MJ; Goodfellow J
J Nutr Biochem; 2004 Feb; 15(2):64-79. PubMed ID: 14972346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
